SHIVA NOROUZI: Open Payments
NPI 1700569944 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 33 payments from 12 companies in 2025. Trend: 2023 $405 · 2024 $1,155 · 2025 $886
Food & beverage: $697Education: $189
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $199 |
| UCB, Inc. | 7 | $179 |
| Regeneron Healthcare Solutions, Inc. | 2 | $116 |
| ABBVIE INC. | 4 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Lilly USA, LLC | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Amgen Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| PFIZER INC. | 1 | $23 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, COSENTYX, TALTZ, Zoryve, Otezla.
Industry payments across WA — which companies pay providers there.
